New mapping tech could make heart ablation more precise

NCT ID NCT07320560

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether a non-invasive global mapping system can help doctors personalize catheter ablation for people with persistent atrial fibrillation (AF). The standard approach isolates the pulmonary veins, but this study adds up to three extra targets based on where the heart shows stable high-rate activity. Researchers will compare outcomes with historical data to see if the personalized approach improves AF termination and reduces recurrence. Forty-five participants will be followed for two years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
catheter ablation guided by non-invasive global mapping
What this could lead to
If successful, this approach could make atrial fibrillation ablation more effective by targeting the specific sources of the arrhythmia in each patient.
What could go wrong
This is a small pilot study with only 45 participants, so results may not apply to everyone. The procedure still carries standard risks of catheter ablation, such as bleeding or heart damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Central Lisbon University Hospital Centre (CHULC), Hospital de Santa Marta

    NOT_YET_RECRUITING

    Lisbon, 1169-024, Portugal

  • Frankfurt University Heart and Vascular Center

    NOT_YET_RECRUITING

    Frankfurt am Main, 60598, Germany

  • German Heart Center of the Charité, Charité University Hospital Berlin

    RECRUITING

    Berlin, 10117, Germany

  • Gregorio Marañón General University Hospital

    NOT_YET_RECRUITING

    Madrid, 28007, Spain

  • Hospital Clinic, University of Barcelona

    NOT_YET_RECRUITING

    Barcelona, 08036, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.